Public Contracts Scotland · Contract

NP33923 Ranibizumab

A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Public Contracts Scotland.

Public Contracts ScotlandContract
Award value
£11.6m
Tender value
4
Suppliers
4
Awards
2
Notices
Contract
Stage

Overview

Supply of ranibizumab injections to NHS Scotland

Key details

Source
Public Contracts Scotland
Lifecycle stage
Contract
Status
active
CPV classification
33600000
Currency
GBP
Total award value
Tender value
£11,600,000
First published
18 Apr 2023
Last updated
27 Jul 2023
View the original notice

Awards

4 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
IRN SECURITY LTDSC490426
Wideblue LtdSC293438
Futura Composites BV
Avid Insurance Services Ltd04885807

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeNP33923 Ranibizumab
  2. Award,contractNP33923 Ranibizumab

All suppliers

Frameworks & programmes

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

FAQs about this procurement

Who is the buyer for "NP33923 Ranibizumab"?

NP33923 Ranibizumab is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Public Contracts Scotland.

Has "NP33923 Ranibizumab" been awarded?

Yes — 4 awards are recorded, with a reported total value of £11,600,000. The current lifecycle stage is "Contract".

Which suppliers are involved in "NP33923 Ranibizumab"?

4 suppliers are linked: IRN SECURITY LTD, Wideblue Ltd, Futura Composites BV, Avid Insurance Services Ltd.

What is "NP33923 Ranibizumab" worth?

The reported tender value is £11,600,000.

When was "NP33923 Ranibizumab" published?

It was first published on 18 Apr 2023 and last updated on 27 Jul 2023, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable